Summary for 8S3X
Entry DOI | 10.2210/pdb8s3x/pdb |
Descriptor | LIM domain kinase 2, 4-(5-cyclopropyl-7~{H}-pyrrolo[2,3-d]pyrimidin-4-yl)-~{N}-[3-(3-methoxyphenyl)phenyl]-3,6-dihydro-2~{H}-pyridine-1-carboxamide (3 entities in total) |
Functional Keywords | kinase, inhibitor, actin cytoskeleton, transferase |
Biological source | Homo sapiens (human) |
Total number of polymer chains | 4 |
Total formula weight | 141061.01 |
Authors | Mathea, S.,Chatterjee, D.,Preuss, F.,Ple, K.,Knapp, S. (deposition date: 2024-02-20, release date: 2024-03-06, Last modification date: 2024-09-18) |
Primary citation | Champire, A.,Berabez, R.,Braka, A.,Cosson, A.,Corret, J.,Girardin, C.,Serrano, A.,Aci-Seche, S.,Bonnet, P.,Josselin, B.,Brindeau, P.,Ruchaud, S.,Leguevel, R.,Chatterjee, D.,Mathea, S.,Knapp, S.,Brion, R.,Verrecchia, F.,Vallee, B.,Ple, K.,Benedetti, H.,Routier, S. Tetrahydropyridine LIMK inhibitors: Structure activity studies and biological characterization. Eur.J.Med.Chem., 271:116391-116391, 2024 Cited by PubMed: 38669909DOI: 10.1016/j.ejmech.2024.116391 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.59 Å) |
Structure validation
Download full validation report